We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Agilent Technologies and Lipomics Collaborate

By Labmedica staff writers
Posted on 20 Feb 2007
Agilent Technologies Inc., (Santa Clara, CA, USA) and Lipomics Technologies Inc., (West Sacramento, CA, USA) will collaborate to develop diagnostic and research assays combining Agilent analytic platforms with Lipomics' expertise in biomarker discovery and validation.

The assays will focus on metabolic diseases, a family of related disorders driven in large part by subtle, long-term dysregulation of lipid metabolism. More...
Lipomics Technologies provides quantitative, diagnostically accurate measurements of more than 1,500 metabolites, allowing comprehensive profiling of whole-body lipid metabolism. The company's quantitative methods and expertise in lipid biology drive development of clinically relevant diagnostic and research assays. A wide range of Agilent liquid and gas chromatography, hyphenated technique instrumentation, reagents, microarrays, and informatics software will be deployed as needed.

Lipomics has developed considerable expertise in investigating the role that lipid metabolism plays in disease mechanisms, said Michael McNulty, general manager of Diagnostics, Agilent Life Sciences and Chemical Analysis. Both companies see significant synergies in combining this expertise with Agilent's capabilities to separate, detect, and analyze molecules in the development of new diagnostic tools.

We look forward to building clinically relevant diagnostic products together, said Meeta Patnaik, chief medical officer, Lipomics. Lipid diagnostics are [the] key to managing patients in areas such as cardiovascular risk, CNS disorders and inflammation, and requires the combination of well validated biomarkers and high-throughput technology for commercialization. The Agilent 2100 Bioanalyzer is [the] key to the collaboration, as the microfluidic-based lab-on-a-chip system delivers the analytic performance, automation, and low sample consumption required to study metabolic biomarkers.

Lipomics Technologies provides metabolic assessments for clinical diagnostics, personalized medicine, and drug research. The company's analytic technologies generate comprehensive, accurate, and quantitative profiles of lipid metabolites.

Agilent's bio-analytic measurement business provides application-focused solutions that include instruments, software, consumables, and services that enable customers to identify, quantify, and analyze the physical and biologic properties of substances and products.




Related Links:
Agilent
Lipomics

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Staining Management Software
DakoLink
New
Automated PCR Setup
ESTREAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.